Skip to main content
Daesung Microbiological Labs. Co. Ltd logo

Daesung Microbiological Labs. Co. Ltd — Investor Relations & Filings

Ticker · 036480 ISIN · KR7036480002 KO Manufacturing
Open in API
Filings indexed 126 across all filing types
Latest filing 2025-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 036480

About Daesung Microbiological Labs. Co. Ltd

https://eng.dsmbio.co.kr/

Daesung Microbiological Labs. Co., Ltd. is a company specializing in the development, manufacturing, and distribution of animal pharmaceuticals. Established in 1968, it is a leading vaccine manufacturer operating under KVGMP (Korean Veterinary Good Manufacturing Practice) standards. The company's product portfolio includes a comprehensive range of vaccines, antibiotics, parasiticides, and nutritional supplements. These products are designed for the health and well-being of livestock such as swine, bovine, and poultry, as well as for companion animals like canines. Daesung Microbiological Labs is committed to achieving disease-free livestock through continuous research and technological innovation in animal health.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from Daesung Microbiological Labs titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper), key financial data, and details regarding the audit process. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body (KRX), rather than the full annual report itself. Therefore, it is classified as an Audit Report/Information document. FY 2024
2025-03-18 Korean
사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 59th fiscal year (2024), covering detailed financial statements, management analysis, governance, and operational data. It is a full-year statutory filing submitted to the Financial Supervisory Service and the Korea Exchange. Based on the content, structure, and the 'Annual Report' definition provided, this is a 10-K equivalent. FY 2024
2025-03-18 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for the 59th Annual General Meeting of Daesung Microbiological Labs. It contains the meeting agenda, director nomination details, and financial statements (balance sheet, income statement, etc.) to be approved by shareholders. According to the filing definitions, documents providing information and requesting votes for meetings are classified as Proxy Solicitation & Information Statements.
2025-03-10 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Daesung Microbiological Labs. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including financial statement approval, director appointments, and remuneration limits. This type of document is a standard proxy solicitation/notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Daesung Microbiological Labs) announcing a significant change (greater than 15% or 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for preliminary financial results before the final audit is completed. Since it provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change, it fits the definition of an Earnings Release (ER). FY 2024
2025-02-11 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Daesung Microbiological Labs regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected date of the general meeting for approval. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2025-02-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.